Results 241 to 250 of about 221,497 (291)

MRI-derived atrophy in multiple system atrophy aligns with mitochondrial and glial gene expression patterns. [PDF]

open access: yesNPJ Parkinsons Dis
Chougar L   +19 more
europepmc   +1 more source

End‐to‐End Sensing Systems for Breast Cancer: From Wearables for Early Detection to Lab‐Based Diagnosis Chips

open access: yesAdvanced Materials Technologies, EarlyView.
This review explores advances in wearable and lab‐on‐chip technologies for breast cancer detection. Covering tactile, thermal, ultrasound, microwave, electrical impedance tomography, electrochemical, microelectromechanical, and optical systems, it highlights innovations in flexible electronics, nanomaterials, and machine learning.
Neshika Wijewardhane   +4 more
wiley   +1 more source

Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment. [PDF]

open access: yesPharmacoecon Open
Grand TS   +10 more
europepmc   +1 more source

Neuronal-specific antibody in patients with multiple system atrophy and progressive supranuclear palsy. [PDF]

open access: yesJ Formos Med Assoc
Fang MS   +18 more
europepmc   +1 more source

Revisiting 'hot cross bun' sign: a multicentre MRI study of 97 patients with autopsy-confirmed multiple system atrophy. [PDF]

open access: yesJ Neurol Neurosurg Psychiatry
Sugiyama A   +24 more
europepmc   +1 more source

Alterations of the skin microbiome in multiple system atrophy: a pilot study. [PDF]

open access: yesNPJ Parkinsons Dis
Chen D   +15 more
europepmc   +1 more source

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy. [PDF]

open access: yesAnn Neurol
Vijiaratnam N   +29 more
europepmc   +1 more source

Multiple-System Atrophy [PDF]

open access: yesNew England Journal of Medicine, 2015
Fanciulli and Wenning's review (Jan. 15 issue) on multiple-system atrophy is comprehensive and up to date. In it, the authors state that the open-label administration of gabapentin could ameliorate cerebellar symptoms in single cases of this disease ...
Benoit, Peyronnet   +2 more
openaire   +8 more sources

Neurofilament light levels predict clinical progression and death in multiple system atrophy [PDF]

open access: yesBrain, 2022
Disease-modifying treatments are currently being trialed in multiple system atrophy (MSA). Approaches based solely on clinical measures are challenged by heterogeneity of phenotype and pathogenic complexity.
Carlo Wilke   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy